Çim, E.F.A.Çim, N.Değer, Ö.D.2025-05-102025-05-1020151301-08832-s2.0-85012994422https://hdl.handle.net/20.500.14720/183Paliperidone is an atypical antipsychotic derived from the combination of 9-hydroxy risperidone which is an active metabolite of risperidone with OROS (osmotic controlled-release oral delivery system) technology. Galactorrhea may develop as a result of hyperprolactinemia caused by paliperidone use. In our case, paliperidone was added to the treatment of a 35-year old female patient having a hypomanic episode. 2.5 months after the start of paliperidone treatment, the patient experienced galactorrhea and menstruation delays. Unexpectedly, normal hyperprolactinemia does not accompany galactorrhea and other symptoms. © 2015, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.eninfo:eu-repo/semantics/closedAccessGalactorrheaHyperprolactinemiaPaliperidoneArticle204N/AQ4251253